|
|
||||||||
1 Laboratory of Human Nutrition, School of Science and Clinical Research Center, Massachusetts Institute of Technology, Cambridge 02139; 2 Boston Burns Hospital, Boston 02114; and 3 MassTrace, Woburn, Massachusetts 08108
L-5-oxoproline (L-5-OP) is an
intermediate in glutathione synthesis, possibly limited by cysteine
availability. Urinary 5-OP excretion has been proposed as a measure of
glycine availability. We investigated whether 5 days of dietary sulfur
amino acid (SAA-free) or glycine (Gly-free) restriction affects plasma
kinetics of 5-OP and urinary excretion of L- and
D-5-OP in 6 healthy men. On day 6, L-5-[1-13C]oxoproline and
[3,3-2H2]cysteine were infused
intravenously for 8 h (3 h fast/5 h fed). In a control study (adequate
amino acid mixture), plasma oxoproline fluxes were 37.8 ± 13.8 (SD)
and 38.4 ± 14.8 µmol · kg
1 · h
1;
oxidation accounted for 85% of flux. Cysteine flux was 47.9 ± 8.5 and 43.2 ± 8.5 µmol · kg
1 · h
1
for fast and fed phases, respectively. Urinary excretion of
L- and D-5-OP was 70 ± 34 and 31.1 ± 13.3 µmol/mmol creatinine, respectively, during days 3-5, and
46.4 ± 13.9 and 22.4 ± 8.3 µmol/mmol over the 8-h tracer study.
The 5-OP flux for the Gly-free diet was higher (P = 0.018) and tended to be higher for the SAA-free diet (P = 0.057) when compared with the control diet. Oxidation rates were higher
on the Gly-free (P = 0.005) and SAA-free (P = 0.03) diets. Cysteine fluxes were lower on the the Gly-free (P = 0.01) and the SAA-free diets (P = 0.001) compared with
the control diet. Rates of L-5-OP excretion were unchanged
by withdrawal of SAA or Gly for 5 days but increased on day 6 (P = 0.005 and P = 0.019, respectively). Thus
acute changes in the dietary availability of SAA and Gly alter
oxoproline kinetics and urinary 5-OP excretion.
oxoproline kinetics; glutathione metabolism; cysteine; dietary intake
This article has been cited by other articles:
![]() |
A. Z. Fenves, H. M. Kirkpatrick III, V. V. Patel, L. Sweetman, and M. Emmett Increased Anion Gap Metabolic Acidosis as a Result of 5-Oxoproline (Pyroglutamic Acid): A Role for Acetaminophen Clin. J. Am. Soc. Nephrol., May 1, 2006; 1(3): 441 - 447. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-M. Yu, C. M. Ryan, Z.-W. Fei, X.-M. Lu, L. Castillo, J. T. Schultz, R. G. Tompkins, and V. R. Young Plasma L-5-oxoproline kinetics and whole blood glutathione synthesis rates in severely burned adult humans Am J Physiol Endocrinol Metab, February 1, 2002; 282(2): E247 - E258. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |